A randomized, double-blind, placebo-controlled add-on trial of quetiapine in outpatients with bipolar disorder and alcohol use disorders

Journal of Clinical Psychiatry

Volumn 69, Issue 5, 2008, Pages 701-705

  Brown, E Sherwood ^a   Garza, Monica ^a   Carmody, Thomas J ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; HYPNOTIC AGENT; LITHIUM; PLACEBO; QUETIAPINE; SEDATIVE AGENT;

ADD ON THERAPY; ADULT; ALCOHOL ABUSE; ALCOHOL CONSUMPTION; ALCOHOLISM; ARTICLE; BIPOLAR I DISORDER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG DOSE TITRATION; DRUG EFFICACY; FATIGUE; FEMALE; HAMILTON SCALE; HUMAN; INDIGESTION; MAJOR CLINICAL STUDY; MALE; MOOD; OUTPATIENT; PRIORITY JOURNAL; PSYCHOLOGICAL RATING SCALE; RANDOMIZED CONTROLLED TRIAL; REGRESSION ANALYSIS; SEDATION; SIDE EFFECT; STATISTICAL SIGNIFICANCE; SYMPTOM; XEROSTOMIA;

EID: 45249117464     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v69n0502     Document Type: Article

References (23)

1. Cassidy F, Ahearn EP, Carroll BJ. Substance abuse in bipolar disorder. Bipolar Disord 2001;3:181-188
2. Regier DA, Farmer ME, Rae DS, et al. Comorbidity of mental disorders with alcohol and other drug abuse: results from the Epidemiologic Catchment Area (ECA) Study. JAMA 1990;264:2511-2518
3. Singh J, Mattoo SK, Sharan P, et al. Quality of life and its correlates in patients with dual diagnosis of affective disorder and substance dependence. Bipolar Disord 2005;7:187-191
4. Himmelhoch JM, Garfinkel M. Sources of lithium resistance in mixed mania. Psychopharmacol Bull 1986;22:613-620
5. Sonne SC, Brady KT, Morton WA. Substance abuse and bipolar affective disorder. J Nerv Ment Dis 1994;182:349-352
6. Feinman JA, Dunner DL. The effect of alcohol and substance abuse on the course of bipolar affective disorder. J Affect Disord 1996;37:43-49
7. Scott H, Johnson S, Menezes P, et al. Substance misuse and risk of aggression and offending among the severely mentally ill. Br J Psychiatry 1998;172:345-350
8. Aagaard J, Vestergaard P. Predictors of outcome in prophylactic lithium treatment: a 2-year prospective study. J Affect Disord 1990;18:259-266
9. Salloum IM, Cornelius JR, Daley DC, et al. Efficacy of valproate maintenance in patients with bipolar disorder and alcoholism: a double-blind placebo-controlled study. Arch Gen Psychiatry 2005;62:37-45
10. Brown ES, Nejtek VA, Perantie DC. Quetiapine in bipolar disorder and cocaine dependence. Bipolar Disord 2002;4:406-411
11. Brown ES, Nejtek VA, Perantie DC, et al. Cocaine and amphetamine use in patients with psychiatric illness: a randomized trial of neuroleptic continuation or discontinuation. J Clin Psychopharmacol 2003;23:384-388
12. Longoria J, Brown ES, Perantie DC, et al. Quetiapine for alcohol use and craving in bipolar disorder. J Clin Psychopharmacol 2004;24:101-102
13. Hamilton M. A rating scale for depression. J Neurosurg Psychiatry 1960;23:56-62
14. Young RC, Biggs JT, Ziegler VE, et al. A rating scale for mania: reliability, validity, and sensitivity. Br J Psychiatry 1978;133:429-435
15. Flannery BA, Volpicelli JR, Pettinati HM. Psychometric properties of the Penn Alcohol Craving Scale. Alcohol Clin Exp Res 1999;23:1287-1288
16. Psychopharmacology Research Branch, National Institute of Mental Health. Abnormal Involuntary Movement Scale (AIMS). In: Guy W. ECDEU Assessment Manual for Psychopharmacology. Rev. ed. US Dept Health, Education, and Welfare Publication (ADM) 76-338. Rockville, Md: National Institute of Mental Health; 1976:534-537
17. Simpson GM, Angus JW. A rating scale for extrapyramidal side effects. Acta Psychiatr Scand Suppl 1970;45(suppl 212):11-19
18. Barnes TRE. A rating scale for drug-induced akathisia. Br J Psychiatry 1989;154:672-676
19. Kashner TM, Carmody TJ, Suppes T, et al. Catching up on health outcomes: the Texas Medication Algorithm Project, pt 1. Health Serv Res 2003;38:311-331
20. Kampman KM, Pettinati HM, Lynch KG, et al. A double-blind, placebo-controlled pilot trial of quetiapine for the treatment of Type A and Type B alcoholism. J Clin Psychopharmacol 2007;27:344-351
21. Calabrese JR, Keck PE, Macfadden W, et al. A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression. Am J Psychiatry 2005;162:1351-1360
22. Thase ME, Macfadden W, Weisler RH, et al. Efficacy of quetiapine monotherapy in bipolar I and II depression: a double-blind, placebo-controlled study (the BOLDER II study). J Clin Psychopharmacol 2006;26:600-609
23. Cookson J, Keck PE Jr, Ketter TA, et al. Number needed to treat and time to response/remission for quetiapine monotherapy efficacy in acute bipolar depression: evidence from a large, randomized, placebo-controlled study. Int Clin Psychopharmacol 2007;22:93-100